Mitochondrial involvement in amyotrophic lateral sclerosis.
about
Impairment of mitochondrial calcium handling in a mtSOD1 cell culture model of motoneuron diseaseOlesoxime, a cholesterol-like neuroprotectant for the potential treatment of amyotrophic lateral sclerosisVgf is a novel biomarker associated with muscle weakness in amyotrophic lateral sclerosis (ALS), with a potential role in disease pathogenesisSkeletal Muscle Satellite Cells, Mitochondria, and MicroRNAs: Their Involvement in the Pathogenesis of ALSMitochondrial pathobiology in ALS.Oxidative stress, mitochondrial damage and neurodegenerative diseasesPackaging of single DNA molecules by the yeast mitochondrial protein Abf2pMitochondrial and Cell Death Mechanisms in Neurodegenerative Diseases.Mitochondrial function in human neuroblastoma cells is up-regulated and protected by NQO1, a plasma membrane redox enzyme.Neuronal degeneration and mitochondrial dysfunction.Neurotrophins and neurodegeneration.A novel, efficient, randomized selection trial comparing combinations of drug therapy for ALS.Molecular and cellular pathways of neurodegeneration in motor neurone diseaseDifferential expression of sirtuins in the aging rat brainMicroRNA-27b Regulates Mitochondria Biogenesis in Myocytes.A multi-center screening trial of rasagiline in patients with amyotrophic lateral sclerosis: Possible mitochondrial biomarker target engagement.Amyotrophic lateral sclerosis and the clinical potential of dexpramipexole.Biology of mitochondria in neurodegenerative diseases.Functional classification of skeletal muscle networks. II. Applications to pathophysiology.Implications for the kynurenine pathway and quinolinic acid in amyotrophic lateral sclerosis.Neuroprotective and Angiogenic Effects of Bone Marrow Transplantation Combined With Granulocyte Colony-Stimulating Factor in a Mouse Model of Amyotrophic Lateral Sclerosis.The mitochondrial permeability transition in neurologic diseaseGlutamate excitotoxicity and therapeutic targets for amyotrophic lateral sclerosis.Nutrition and dietary supplements in motor neuron disease.MicroRNAs in skeletal muscle and their regulation with exercise, ageing, and disease.Evidence for defective energy homeostasis in amyotrophic lateral sclerosis: benefit of a high-energy diet in a transgenic mouse model.Mitochondrial damage revealed by immunoselection for ALS-linked misfolded SOD1.A(a)LS: Ammonia-induced amyotrophic lateral sclerosis.Mitochondrial DNMT3A and DNA methylation in skeletal muscle and CNS of transgenic mouse models of ALS.The mitochondrial permeability transition pore: a molecular target for amyotrophic lateral sclerosis therapy.An insight into ultrastructural and morphological alterations of platelets in neurodegenerative diseases.Exercise and amyotrophic lateral sclerosis.Role of platelets in neurodegenerative diseases: a universal pathophysiology.Amyotrophic Lateral Sclerosis and Metabolomics: Clinical Implication and Therapeutic Approach.Gene expression profile of SOD1-G93A mouse spinal cord, blood and muscle.Cell stress induces TDP-43 pathological changes associated with ERK1/2 dysfunction: implications in ALS.Cerebrospinal Fluid from Sporadic Amyotrophic Lateral Sclerosis Patients Induces Mitochondrial and Lysosomal Dysfunction.Intrathecal upregulation of granulocyte colony stimulating factor and its neuroprotective actions on motor neurons in amyotrophic lateral sclerosis.Percutaneous endoscopic gastrostomy, body weight loss and survival in amyotrophic lateral sclerosis: a population-based registry study.Mitochondrial respiratory chain function in skeletal muscle of ALS patients.
P2860
Q21262978-71B257FC-3B35-433B-8FAA-34E75AA50873Q24596378-2D28FED5-D137-4D70-9AAF-29CA3CC39B57Q24644968-899FCE74-5AB9-4E65-B093-4AABC5D450FAQ28075355-F91BA51C-9175-40E0-ABA2-B6A4A84E8854Q34038775-761BD616-7168-4D74-9739-03EEF283B95CQ34094532-E0DAFD51-69FE-4993-99AC-F01AFFAD86D1Q34183141-E8476BFF-6DBE-4D24-BBB2-4A57C1614243Q34502221-A3277785-52B0-4685-BECC-4E122386C22EQ34852496-BDBDB014-4A75-4C83-AFC3-C696DB024043Q35060350-BF06EDE4-9432-48B8-86FB-9665B5DDD227Q35145450-F2B0DAB9-47D6-4FDB-9915-6E4A6DA8F76FQ35162749-72FA0421-3D7D-4739-8B77-C4331EEC6D96Q35489359-124EBBA5-4552-4775-BC0E-0F8290EE0D41Q35584969-885A8D8D-79B2-4E1A-89F4-E903C98F4625Q35915902-6CAAFC45-AC30-462A-BDD3-DC639B1302B2Q36177001-5EB39F06-AC7B-43A8-8603-8B3B79266795Q36202825-ABD34ED9-B099-477D-A01D-91343CA880DBQ36488715-35441590-0656-46E8-A856-2A5DC40226D2Q36530917-A0DCD141-6EC7-4685-8755-2837F1C98770Q36565671-737F45B0-8451-472A-9AFA-FF08F1EB83D0Q36680605-227726B3-F2F6-456B-8C59-6F1D8D7A0B97Q36775895-92A054A0-B99A-4EAC-A6F8-A22FA47A067EQ37008837-C6FEE795-B687-49B9-A363-41D90D36CB14Q37073851-AC1A9590-E6B6-4BBF-B91C-BFC1D02BE1D3Q37205421-7A9E590B-A847-4A11-8BE5-D9C4E93FDB72Q37285915-AA1C615F-DB49-4D24-B9BB-82462CBD0B3DQ37313745-B753030A-94E1-49B7-91CE-76C753C0EAC4Q37337058-DE2A955A-5B88-472E-8EA3-CE576EDE3AD7Q37413126-9218C9FF-9F48-484C-8EA8-0B02515AD064Q37466115-D8C29D48-900A-46A5-B710-7655A3F3CB98Q37853182-10019D2B-5C9E-4EED-9C24-D6A5397D2146Q37974126-7CED1230-7C17-4B9A-BAC9-F5646A7FA734Q38072757-BC277EE3-852E-4BBB-B34A-DE4F2C8DE44FQ38575783-4958C4A3-FA71-43B2-911A-6E859C1C616CQ39489728-D3CD2086-A2D6-4D31-8854-A37E1796B720Q39517613-EE1EC2DB-0355-4004-91D1-0A3D615CA33AQ40233562-CEAB4B70-249E-4451-8F60-F0375B6B4209Q40245798-A5463CF8-F9AB-42DA-8255-4FB9A942A1F4Q40385575-EE15B7B1-C8C6-4B56-B792-40327E1C963DQ42527324-2422E4D1-713E-42AC-BFA0-8A9CC8F749D1
P2860
Mitochondrial involvement in amyotrophic lateral sclerosis.
description
2002 nî lūn-bûn
@nan
2002 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Mitochondrial involvement in amyotrophic lateral sclerosis.
@ast
Mitochondrial involvement in amyotrophic lateral sclerosis.
@en
Mitochondrial involvement in amyotrophic lateral sclerosis.
@nl
type
label
Mitochondrial involvement in amyotrophic lateral sclerosis.
@ast
Mitochondrial involvement in amyotrophic lateral sclerosis.
@en
Mitochondrial involvement in amyotrophic lateral sclerosis.
@nl
prefLabel
Mitochondrial involvement in amyotrophic lateral sclerosis.
@ast
Mitochondrial involvement in amyotrophic lateral sclerosis.
@en
Mitochondrial involvement in amyotrophic lateral sclerosis.
@nl
P1476
Mitochondrial involvement in amyotrophic lateral sclerosis.
@en
P2093
Fiona M Menzies
Paul G Ince
P304
P356
10.1016/S0197-0186(01)00125-5
P577
2002-05-01T00:00:00Z